The effect of cefazolin on peripheral blood.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004804:Eosinophils / Q000187:drug effects; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006400:Hematocrit; D006413:Hematopoietic System / Q000187:drug effects*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000097:blood; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D011485:Protein Binding / Q000187:drug effects; D012156:Reticulocytes / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology / Q000627:therapeutic use; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D013830:Thiadiazoles / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D002511:Cephalosporins; D006454:Hemoglobins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D007501:Iron